Approximately 172,944 bottles of Doxycycline Capsules (75 mg and 100 mg), a prescription antibiotic, are being recalled because they were not manufactured under Current Good Manufacturing Practice (CGMP) conditions. This recall includes 624 bottles of the 75 mg strength and 172,320 bottles of the 100 mg strength distributed nationwide. While no specific injuries or adverse health effects have been reported in this data, deviations from manufacturing standards can compromise the quality and safety of medication. Consumers should contact their healthcare provider or pharmacist regarding their medication and return any unused product to the place of purchase for a refund.
The drug was not manufactured according to required quality standards, which could lead to potential issues with the medication's purity, potency, or overall quality. Using a medication that does not meet manufacturing standards could result in ineffective treatment of infections or unexpected side effects.
Healthcare guidance and refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.